Phantom boarder syndrome associated with experimentally-induced presence hallucinations in Parkinson’s disease
Objective: Measuring experimentally-induced presence hallucinations in patients with Parkinson’s disease phantom boarder phenomena. Background: Phantom boarder syndrome (PB) is described as the sensation that someone…Month 24 results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort
Objective: To describe the change in characteristics of Parkinson’s disease (PD) clinical trial participants over 24 months following trial participation in a remote, longitudinal observational…A case with clinical features of alpha-synuclein- and tauopathy: Genetic and histopathological workup.
Objective: Here, we present a clinical case that mimicked the coincidence of idiopathic Parkinson’s disease (PD) and tauopathy. Background: Mutation in leucine-rich-repeat-kinase 2 (LRRK2) gene…Programming algorithm for the management of speech impairment in STN-DBS for Parkinson’s disease
Objective: To establish an evidence- and experience-based algorithm for the management of speech impairment (SI) in Parkinson’s disease (PD) patients treated with STN-DBS. Background: STN-DBS…Nigral microvasculature imaging in Parkinson’s disease
Objective: The goal of this work is to image the microvasculature of the midbrain, in particular the substantia nigra in Parkinson’s disease (PD) patients using…Exploratory delayed-start analysis of PASADENA evaluating the efficacy of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease
Objective: To evaluate the effect of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease (PD) using an exploratory delayed-start analysis of Part…Paroxysmal Musician’s Dyskinesia
Objective: To report a case of tics associated with paroxysmal kinesigenic dyskinesia in a patient with PRRT2 mutation. Background: Paroxysmal kinesigenic dyskinesia (PKD) is characterized…History of Comorbidities and their Association with Developing Cognitive Dysfunction in PD
Objective: To examine comorbidities associated with incident cognitive dysfunction in PD. Background: The risk of dementia is up to six-times higher in PD compared to…Utilisation of the Clinical Frailty Scale to prompt transfer of patients with Parkinson’s disease from Neurology to Geriatric Medicine services.
Objective: The aim of this study was to determine the feasibility of the Clinical Frailty Scale (CFS) as a tool to trigger clinicians' transfer of…Eye closure during tasks in blepharospasm (BSP)
Objective: To quantify modulation of eye closure rates during activities of daily living in individuals with BSP and asymptomatic individuals with and without family history…
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 153
- Next Page »